{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:38:30Z","timestamp":1790365110949,"version":"4.1.0"},"reference-count":81,"publisher":"Bentham Science Publishers Ltd.","issue":"20","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MRMC"],"published-print":{"date-parts":[[2021,1,14]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Triazine is the six-membered heterocyclic ring containing three nitrogens, which replace the\ncarbon-hydrogen unit in the benzene ring. Based on nitrogen position present in the ring system, it is\ncategorized in three isomeric forms, i.e., 1, 2, 3-triazine (vicinal triazine), 1, 2, 4-triazine (asymmetrical\ntriazine or isotriazine) and 1, 3, 5-triazine (symmetrical or s-triazine or cyanidine). Triazines have\na weakly basic property. Their isomers have much weaker resonance energy than benzene structure, so\nnucleophilic substitution reactions are more preferred than electrophilic substitution reactions. Triazine\nisomers and their derivatives are known to play important roles possessing various activities in medicinal\nand agricultural fields such as anti-cancer, antiviral, fungicidal, insecticidal, bactericidal, herbicidal,\nantimalarial and antimicrobial agents.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389557520666200729160720","type":"journal-article","created":{"date-parts":[[2020,8,9]],"date-time":"2020-08-09T08:06:16Z","timestamp":1596960376000},"page":"2104-2122","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["The Chemistry of Triazine Isomers: Structures, Reactions, Synthesis and Applications"],"prefix":"10.2174","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9653-1313","authenticated-orcid":true,"given":"Neelottama","family":"Kushwaha","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, BN College of Pharmacy, Faculty of Pharmacy, BN University, Udaipur, Rajasthan-313001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1332-623X","authenticated-orcid":true,"given":"C.S.","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, BN College of Pharmacy, Faculty of Pharmacy, BN University, Udaipur, Rajasthan-313001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.1016\/S0040-4039(01)00766-3","volume":"42","author":"Yang R.","year":"2001","unstructured":"Yang R.; Kaplan P.A.; Reaction of isothiourea with 2, 3-diaza-3- pentenedioic anhydride: A solid-phase synthesis of 3-amino-1, 2, 4-triazin-5(4H)-ones. Tetrahedron Lett 2001,42,4433-4435","journal-title":"Tetrahedron Lett"},{"key":"ref=2","author":"Hirai K.","year":"1986","unstructured":"Hirai K.; Sugimoto H.; Mizushima T.J.; Triazinone derivative and antitumor agent JP: 61134389 A2, 1986"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/ps.2780330402","volume":"33","author":"Oettmeier W.","year":"1991","unstructured":"Oettmeier W.; Hilp U.; Draber W.; Fedtke C.; Schmidt R.R.; Structure-activity relationships of triazinone herbicides on resistant weeds and resistant chlamydomonas reinhardtii. Pesticidal Society 1991,33,399-409","journal-title":"Pesticidal Society"},{"key":"ref=4","author":"Kranz E.","year":"1990","unstructured":"Kranz E.; Santel H.; Luerssen K.; New 6-cyclo-butyl-1, 2, 4-triazinone derivs\u2014useful as herbicides and plant growth regulators DE: 3917043 A1 1990"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"3840","DOI":"10.1021\/jm0402014","volume":"48","author":"Migawa M.T.","year":"2005","unstructured":"Migawa M.T.; Drach J.C.; Townsend L.B.; Design, synthesis and antiviral activity of novel 4,5-disubstituted 7-(beta-D-ribofuranosyl)pyrrolo[2,3-d][1,2,3]triazines and the novel 3-amino-5-methyl-1-(beta-D-ribofuranosyl)- and 3-amino-5-methyl-1-(2-deoxy-beta-D-ribofuranosyl)-1,5-dihydro-1,4,5,6,7,8-hexaazaacenaphthylene as analogues of triciribine. J Med Chem 2005,48(11),3840-3851","journal-title":"J Med Chem"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1021\/jm00092a013","volume":"35","author":"Rosowsky A.","year":"1992","unstructured":"Rosowsky A.; Forsch R.A.; Moran R.G.N.; -[4-[[(3,4-dihydro-4-oxo-1,2,3-benzotriazin-6- yl)methyl]amino]benzoyl]-L-glutamic acid, a novel A-ring analogue of 2-desamino-5,8-dideazafolic acid. J Med Chem 1992,35(14),2626-2630","journal-title":"J Med Chem"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0223-5234(99)80074-9","volume":"33","author":"Garutia L.","year":"1998","unstructured":"Garutia L.; Roberti M.; Rossi T.; Castelli M.; Malagoli M.; Synthesis and antiproliferative activity of 3-substituted 1H-indole [3, 2-d] 1, 2, 3-triazin-4 (3H)-ones. Eur J Med Chem 1998,33,43-46","journal-title":"Eur J Med Chem"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"3994","DOI":"10.1248\/cpb.30.3994","volume":"30","author":"Ochiai M.","year":"1982","unstructured":"Ochiai M.; Fujita E.; Arimoto M.; Yamaguchi H.; Heterocyclic synthesis. Chem Pharm Bull (Tokyo) 1982,30,3994-3999","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejmech.2017.06.003","volume":"142","author":"Cascioferro S.","year":"2017","unstructured":"Cascioferro S.; Parrino B.; Spano V.; Caobone A.; Montalbano A.; Barraja P.; Diana P.; Cirrincione G.; Synthesis and antitumor activities of 1,2,3-triazine and their benzo and heterofused derivatives. Eur J Med Chem 2017,142,1-13","journal-title":"Eur J Med Chem"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"7807","DOI":"10.1016\/j.bmc.2013.10.009","volume":"21","author":"Zhao X.W.","year":"2013","unstructured":"Zhao X.W.; Liu D.; Luan S.L.; Hu G.D.; Lv J.L.; Jing Y.K.; Zhao L.X.; Synthesis and biological evaluation of 1,2,3-benzotrizene and pyrido [3,2-d]-1,2,3-triazine as inhibitor of vascular endothelial growth factor receptor-2. Bioorg Med Chem 2013,21,7807-7815","journal-title":"Bioorg Med Chem"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"72","DOI":"10.2174\/1389557513666140103111017","volume":"14","author":"Kumar R.","year":"2014","unstructured":"Kumar R.; Singh A.D.; Singh J.; Singh H.; Roy R.K.; Chaudhary A.; 1,2,3-Triazine scaffold as a potent biologically active moiety: a mini review. Mini Rev Med Chem 2014,14(1),72-83","journal-title":"Mini Rev Med Chem"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"4581","DOI":"10.3390\/molecules24244581","volume":"24","author":"Zvarych V.","year":"2019","unstructured":"Zvarych V.; Stasevych M.; Novikov V.; Rusanov E.; Vovk M.; Szweda P.; Grecka K.; Milewski S.; Anthra[1,2-d][1,2,3]triazine-4,7,12(3H)-triones as a New class of antistaphylococcal agents: Synthesis and biological evaluation. Molecules 2019,24(24),4581-4600","journal-title":"Molecules"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"24010","DOI":"10.1039\/C5RA26433B","volume":"6","author":"Hamama W.S.","year":"2016","unstructured":"Hamama W.S.; El-Bana G.G.; Shaaban S.; Habib O.M.O.; Zoorob H.H.; Advances in the domain of 4-amino-3-mercapto- 1,2,4-triazine-5-ones. RSC Advances 2016,6,24010-24049","journal-title":"RSC Advances"},{"key":"ref=14","first-page":"347","volume":"54","author":"Abdel-Rahman R.M.","year":"1999","unstructured":"Abdel-Rahman R.M.; Morsy J.M.; Hanafy F.; Amene H.A.; Synthesis of heterobicyclic nitrogen systems bearing the 1,2,4-triazine moiety as anti-HIV and anticancer drugs: Part I. Pharmazie 1999,54(5),347-351","journal-title":"Pharmazie"},{"key":"ref=15","first-page":"667","volume":"54","author":"Abdel-Rahman R.M.","year":"1999","unstructured":"Abdel-Rahman R.M.; Morsy J.M.; el-Edfawy S.; Amine H.A.; Synthesis of some new heterobicyclic nitrogen systems bearing the 1,2,4-triazine moiety as anti-HIV and anti-cancer drugs, Part II. Pharmazie 1999,54(9),667-671","journal-title":"Pharmazie"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1021\/jm00192a012","volume":"22","author":"Heilman W.P.","year":"1979","unstructured":"Heilman W.P.; Heilman R.D.; Scozzie J.A.; Wayner R.J.; Gullo J.M.; Ariyan Z.S.; Synthesis and antihypertensive activity of novel 3-hydrazino-5-phenyl-1,2,4-triazines. J Med Chem 1979,22(6),671-677","journal-title":"J Med Chem"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/BF02174527","volume":"1","author":"Topliss J.G.","year":"1993","unstructured":"Topliss J.G.; Some observations on classical QSAR. Perspect Drug Discov Des 1993,1,253-268","journal-title":"Perspect Drug Discov Des"},{"key":"ref=18","first-page":"278","volume":"7","author":"Ambhore A.N.","year":"2015","unstructured":"Ambhore A.N.; Surywanshi V.D.; Kamble R.D.; Shrikant V.H.; Mogle P.P.; Kadam S.S.; Dawane B.S.; Synthesis and biological investigation of isoxazolo[4,5-e][1,2,4]triazine derivatives. Pharma Chem 2015,7,278-283","journal-title":"Pharma Chem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.3762\/bjoc.9.265","volume":"9","author":"Baumann M.","year":"2013","unstructured":"Baumann M.; Baxendale I.R.; An overview of the synthetic routes to the best selling drugs containing 6-membered heterocycles. Beilstein J Org Chem 2013,9,2265-2319","journal-title":"Beilstein J Org Chem"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1159\/000500702","volume":"104","author":"Qiang Z.","year":"2019","unstructured":"Qiang Z.; Yu W.; Yu Y.; Design and development of novel 1,3,5-Triazine-Procaine derivatives as Protective agent against Myocardial ischemia\/ Reperfusion injury via inhibitor of Nuclear factor-KB. Pharmacology 2019,104(3-4),126-138","journal-title":"Pharmacology"},{"key":"ref=21","first-page":"101","volume":"7","author":"Rao D.S.","year":"2016","unstructured":"Rao D.S.; Kumar G.V.P.; Pooja B.; Harika G.; Kumar Y.A.; Rao G.S.; An extensive review on 1,2,3 and 1,2,4-triazines scaffold-valuable lead molecules with potent and diverse pharmacological activities. Der Chemica Sinica 2016,7,101-130","journal-title":"Der Chemica Sinica"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21577\/0103-5053.20190096","volume":"0","author":"Fiorot R.G.","year":"2019","unstructured":"Fiorot R.G.; Westphal R.; Lemos B.C.; Romagna R.A.; Gonclaves P.L.; Fernandes M.R.N.; Ferriera C.V.; Taranto A.G.; Greco S.J.; Synthesis, Molecular Modelling and Anticancer activities of new molecular hybrids containing 1,4- Naphthoquinone, 7-Chloroquinoline, 1,3,5- Triazine and morpholine cores as P13K and AMPK inhibitors in the metastatic melanoma cells. J Braz Chem Soc 2019,0,1-14","journal-title":"J Braz Chem Soc"},{"key":"ref=23","author":"Kar A.","year":"2010","unstructured":"Kar A.;  Medicinal Chemistry 2010","journal-title":"Medicinal Chemistry"},{"key":"ref=24","first-page":"64","volume":"32","author":"Stukov A.N.","year":"1986","unstructured":"Stukov A.N.; Korsakov M.V.; Khrapova T.N.; Kil\u2019maeva N.E.; Kra\u012dz B.O.; Effect of dioxadet on tumors transplanted to the brain. Vopr Onkol 1986,32(10),64-67","journal-title":"Vopr Onkol"},{"key":"ref=25","first-page":"58","volume":"59","author":"Stukov A.N.","year":"1996","unstructured":"Stukov A.N.; Filov V.A.; Kon\u2019kov S.A.; Ivin B.A.; The pharmacological properties of preparations from the aziridinyl triazine group. Eksp Klin Farmakol 1996,59(1),58-60","journal-title":"Eksp Klin Farmakol"},{"key":"ref=26","first-page":"771","volume":"57","author":"Bespalov V.G.","year":"2011","unstructured":"Bespalov V.G.; Beliaeva O.A.; Panchenko A.V.; Stukov A.N.; Gershanovich M.L.; Murazov IaG.; Kon\u2019kov S.A.; Kil\u2019maeva N.E.; Krylova I.M.; Mironiuk T.A.; Latipova D.Kh.; Antitumor activity of dioxadet compared with cisplatin on ascitic ovarian tumor in rats. Vopr Onkol 2011,57(6),771-774","journal-title":"Vopr Onkol"},{"key":"ref=27","author":"Tripathi K.D.","year":"2003","unstructured":"Tripathi K.D.; Essentials of medical pharmacologyJaypee brothers medical publishers (P) Ltd: New Delhi, 2003"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1016\/j.bmcl.2007.04.007","volume":"17","author":"Arya K.","year":"2007","unstructured":"Arya K.; Dandia A.; Synthesis and cytotoxic activity of trisubstituted-1,3,5-triazines. Bioorg Med Chem Lett 2007,17(12),3298-3304","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1016\/j.bmc.2006.11.028","volume":"15","author":"Zheng M.","year":"2007","unstructured":"Zheng M.; Xu C.; Ma J.; Sun Y.; Du F.; Liu H.; Lin L.; Li C.; Ding J.; Chen K.; Jiang H.; Synthesis and antitumor evaluation of a novel series of triaminotriazine derivatives. Bioorg Med Chem 2007,15(4),1815-1827","journal-title":"Bioorg Med Chem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"4649","DOI":"10.1021\/jm0495374","volume":"47","author":"Menicagli R.","year":"2004","unstructured":"Menicagli R.; Samaritani S.; Signore G.; Vaglini F.; Dalla Via L.; In vitro cytotoxic activities of 2-alkyl-4,6-diheteroalkyl-1,3,5-triazines: New molecules in anticancer research. J Med Chem 2004,47(19),4649-4652","journal-title":"J Med Chem"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1016\/j.ejmech.2010.02.001","volume":"45","author":"Kumar R.","year":"2010","unstructured":"Kumar R.; Gupta L.; Pal P.; Khan S.; Singh N.; Katiyar S.B.; Meena S.; Sarkar J.; Sinha S.; Kanaujiya J.K.; Lochab S.; Trivedi A.K.; Chauhan P.M.S.; Synthesis and cytotoxicity evaluation of (tetrahydro-beta-carboline)-1,3,5-triazine hybrids as anticancer agents. Eur J Med Chem 2010,45(6),2265-2276","journal-title":"Eur J Med Chem"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"e02347","DOI":"10.1128\/AAC.02347-17","volume":"62","author":"Kondaparla S.","year":"2018","unstructured":"Kondaparla S.; Debnath U.; Soni A.; Dola V.R.; Sinha M.; Srivastava K.; Puri S.K.; Katti S.B.; Synthesis, biological evaluation and molecular modeling studies of chiral chloroquine analogues as antimalarial agents. Antimicrob Agents Chemother 2018,62(12),e02347-17","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=33","author":"Greif G.","year":"2009","unstructured":"Greif G.; Triazinone compounds for treating diseases resulting from infestation with parasitic protozoans US Patent, 20090181040 2009"},{"key":"ref=34","first-page":"1","author":"Stock M.L.","year":"2017","unstructured":"Stock M.L.; Elazab S.T.; Hsu W.H.;  Review of triazine antiprotozoal drugs used in veterinary medicine J Vet Pharmacol Therap 2017,1-11","journal-title":"Review of triazine antiprotozoal drugs used in veterinary medicine J Vet Pharmacol Therap"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.bmcl.2004.11.052","volume":"15","author":"Agarwal A.","year":"2005","unstructured":"Agarwal A.; Srivastava K.; Puri S.K.; Chauhan P.M.; Syntheses of 2,4,6-trisubstituted triazines as antimalarial agents. Bioorg Med Chem Lett 2005,15(3),531-533","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.1016\/j.bmcl.2005.08.023","volume":"15","author":"Katiyar S.B.","year":"2005","unstructured":"Katiyar S.B.; Srivastava K.; Puri S.K.; Chauhan P.M.; Synthesis of 2-[3,5-substituted pyrazol-1-yl]-4,6-trisubstituted triazine derivatives as antimalarial agents. Bioorg Med Chem Lett 2005,15(22),4957-4960","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/cbdd.12490","volume":"86","author":"Bhat H.R.","year":"2015","unstructured":"Bhat H.R.; Singh U.P.; Gahtori P.; Ghosh S.K.; Gogoi K.; Prakash A.; Singh R.K.; Synthesis, docking, in vitro and in vivo antimalarial activity of hybrid 4-aminoquinoline-1,3,5-triazine derivatives against wild and mutant malaria parasites. Chem Biol Drug Des 2015,86(3),265-271","journal-title":"Chem Biol Drug Des"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.exppara.2015.06.016","volume":"157","author":"Bhat H.R.","year":"2015","unstructured":"Bhat H.R.; Singh U.P.; Thakur A.; Ghosh S.K.; Gogoi K.; Prakash A.; Singh R.K.; Synthesis, antimalarial activity and molecular docking of hybrid 4-aminoquinoline-1,3,5-triazine derivatives. Experiment Parasitol 2015,157,59-67","journal-title":"Experiment Parasitol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"S625","DOI":"10.1016\/j.arabjc.2011.07.001","volume":"9","author":"Bhat H.R.","year":"2016","unstructured":"Bhat H.R.; Singh U.P.; Yadav P.S.; Kumar V.; Gahtori P.; Das A.; Chetia D.; Prakash A.; Mahanta J.; Synthesis, characterization and antimalarial activity of hybrid 4-aminoquinoline-1,3,5-triazine derivatives. Arab J Chem 2016,9,S625-S631","journal-title":"Arab J Chem"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/jhet.93","volume":"46","author":"Klimova E.I.","year":"2009","unstructured":"Klimova E.I.; Klimova T.; Alamo M.F.; Iturbide D.M.; Garcia M.M.; Synthesis, structure and some chemical properties of Diferrocenyl-1,2,3-triazine. Heterocyclic Chem 2009,46,477-483","journal-title":"Heterocyclic Chem"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1039\/p19750000031","author":"Adger B.M.","year":"1975","unstructured":"Adger B.M.; Bradbury S.; Keating M.; Charles W.R.; Storr R.C.; Williams M.T.; 1,2,3-Benzotriazines. J Chem Soc, Perkin Trans 1 1975,31-40","journal-title":"J Chem Soc, Perkin Trans 1"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"7807","DOI":"10.1016\/j.bmc.2013.10.009","volume":"21","author":"Zhao X.W.","year":"2013","unstructured":"Zhao X.W.; Liu D.; Luan S.L.; Hu G.D.; Lv J.L.; Jing Y.K.; Zhao L.X.; Synthesis and biological evaluation of substituted 1,2,3-benzotriazines and pyrido[3,2-d]-1,2,3-triazines as inhibitors of vascular endothelial growth factor receptor-2. Bioorg Med Chem 2013,21(24),7807-7815","journal-title":"Bioorg Med Chem"},{"key":"ref=43","first-page":"765","author":"Stevens H.N.E.","year":"1970","unstructured":"Stevens H.N.E.; Stevens M.F.G.; Part III. Synthesis and rearrangement of 3,4-dihydro-4-imino-1,2,3-benzotriazines J. Chem. Soc C: Organic Triazines and related products 1970,765-771","journal-title":"Triazines and related products"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1002\/jhet.5570070403","volume":"7","author":"Paudler W.W.","year":"1970","unstructured":"Paudler W.W.; Chen T.K.; 1, 2, 4-triazine. III.A Conveninent synthesis of 1, 2, 4-triazine and their covalent hydration. J Heterocycl Chem 1970,7,767-771","journal-title":"J Heterocycl Chem"},{"key":"ref=45","first-page":"79","author":"Phucho I.T.","year":"2008","unstructured":"Phucho I.T.; Nongpiur A.; Tumtin S; Nongrum R.; Myrboh B.; Nongkhlaw R.L.; Novel one pot synthesis of substituted 1, 2, 4-triazines Archive for organic chemistry 2008,79-87"},{"key":"ref=46","author":"Neunhoeffer H.","year":"1978","unstructured":"Neunhoeffer H.; Wiley P.F.; Chemistry of 1 2 3-Triazines and 1 2 4-Triazines, trazines, and Pentazin 1978"},{"key":"ref=47","author":"Elks J.","year":"1990","unstructured":"Elks J.; Ganellin C.R.; The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and bibliographies, edi. First Sringerscience+business media, B.V, 1990"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"3982","DOI":"10.1021\/ol901626n","volume":"11","author":"Tang S.","year":"2009","unstructured":"Tang S.; He J.; Sun Y.; He L.; She X.; Efficient and regioselective one-pot synthesis of 3-substituted and 3,5-disubstituted isoxazoles. Org Lett 2009,11(17),3982-3985","journal-title":"Org Lett"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"15644","DOI":"10.1021\/ja0547937","volume":"127","author":"Hughes R.A.","year":"2005","unstructured":"Hughes R.A.; Thompson S.P.; Alcaraz L.; Moody C.J.; Total synthesis of the thiopeptide antibiotic amythiamicin D. J Am Chem Soc 2005,127(44),15644-15651","journal-title":"J Am Chem Soc"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.bmcl.2009.11.048","volume":"20","author":"Sangshetti J.N.","year":"2010","unstructured":"Sangshetti J.N.; Shinde D.B.; One pot synthesis and SAR of some novel 3-substituted 5,6-diphenyl-1,2,4-triazines as antifungal agents. Bioorg Med Chem Lett 2010,20(2),742-745","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1016\/j.tetlet.2010.01.034","volume":"51","author":"Kaila J.C.","year":"2010","unstructured":"Kaila J.C.; Baraiya A.B.; Pandya A.N.; Jalani H.B.; Sudarsanam V.; Vasu K.K.; A convenient one-pot synthesis of trisubstituted 1, 3, 5-triazines through intermediary amidinothioureas. Tetrahedron Lett 2010,51,1486-1489","journal-title":"Tetrahedron Lett"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"3492","DOI":"10.1002\/ejoc.201200276","volume":"2012","author":"Biswas S.","year":"2012","unstructured":"Biswas S.; Batra S.; One- Step Synthesis of 2-Amino-5H-pyrimido[5,4-b]indoles, Substituted 2-(1,3,5-triazin-2-yl)-1H-indoles, and 1,3,5-Triazines from Aldehydes. Eur J Org Chem 2012,2012,3492-3499","journal-title":"Eur J Org Chem"},{"key":"ref=53","doi-asserted-by":"publisher","DOI":"10.1002\/9780471739876","author":"Mundy B.P.","year":"2005","unstructured":"Mundy B.P.; Ellerd M.G.; Favaloro F.G.;  Name Reactions and Reagents in Organic Synthesis, A john wiley  2005","journal-title":"Name Reactions and Reagents in Organic Synthesis, A john wiley"},{"key":"ref=54","doi-asserted-by":"crossref","DOI":"10.1002\/0470010428","author":"Laue T.","year":"2005","unstructured":"Laue T.; Plagens A.; Named. Organic Reactions 2005","journal-title":"Organic Reactions"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"13","DOI":"10.15227\/orgsyn.033.0013","volume":"33","author":"Simsons J.K.","year":"1953","unstructured":"Simsons J.K.; Saxton M.R.; Working with Hazardous Chemicals: Benzoguanamine. Org Synth 1953,33,13","journal-title":"Org Synth"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1023\/A:1015531315785","volume":"28","author":"Seifer G.B.","year":"2002","unstructured":"Seifer G.B.; Cyanuric Acid and Cyanurates. Russ J Coord Chem 2002,28,301","journal-title":"Russ J Coord Chem"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1155\/2009\/196309","volume":"6","author":"Baldaniya B.B.","year":"2009","unstructured":"Baldaniya B.B.; Patel P.K.; Synthesis, Antibacterial and Antifungal Activities of s-Triazine Derivatives. E-J Chem 2009,6,673-680","journal-title":"E-J Chem"},{"key":"ref=58","first-page":"907","volume":"1981","author":"Harris R.L.N.","year":"1981","unstructured":"Harris R.L.N.;  Synthesis of Triazines from N-Cyanocarbamimidates Synthesis 1981,1981,907-908","journal-title":"Synthesis of Triazines from N-Cyanocarbamimidates Synthesis"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1155\/2010\/612853","volume":"7","author":"Baldaniya B.B.","year":"2010","unstructured":"Baldaniya B.B.; Synthesis and Characterizations of N 2 -(Aryl)-N 4, N 6 - bis (6, 7-dichloro-1, 3-benzothiazol-2-yl)-1, 3, 5- triazine-2, 4, 6-triamines as Biological Potent Agents. E-J Chem 2010,7,210-214","journal-title":"E-J Chem"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1039\/c39830001344","author":"Campbell J.J.A.","year":"1983","unstructured":"Campbell J.J.A.; Noyce S.J.; Storr R.C.; The reaction of 1, 2, 3-benzotriazines with Grignard reagents. J Chem Soc Chem Commun 1983,1344-1346","journal-title":"J Chem Soc Chem Commun"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1248\/cpb.46.332","volume":"46","author":"Koyama J.","year":"1998","unstructured":"Koyama J.; Toyokuni I.; Tagahara T.; Diels-Alder Reaction of 1, 2, 3-Benztriazine with Enamine: Application to the synthesis of Alkaloids, 2-Propylquinoline and 2- Phenylquinoline. Chem Pharm Bull (Tokyo) 1998,46,332-334","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1248\/cpb.47.1038","volume":"47","author":"Koyama J.","year":"1999","unstructured":"Koyama J.; Toyokuni I.; Tagahara T.; Synthesis of 2-Arylquinoline and 2-Aryl-4-quinoline alkaloid via Diels-Alder reaction of 1, 2, 3-Benzotriazine with enamines. Chem Pharm Bull (Tokyo) 1999,47,1038-1039","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1039\/p19880001509","volume":"I","author":"Boulton A.J.","year":"1988","unstructured":"Boulton A.J.; Kiss M.; Saka J.D.K.; 1, 2, 3-Benzotriazine 2-oxides. J Chem Soc Perkin Trans 1988,I,1509-1512","journal-title":"J Chem Soc Perkin Trans"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1039\/jr9630001628","author":"Atkinson C.M.","year":"1963","unstructured":"Atkinson C.M.; Cossey H.D.; 305. Quaternisation of some 1, 2, 4-triazines. J Chem Soc 1963,1628-1635","journal-title":"J Chem Soc"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1021\/jo00323a044","volume":"46","author":"Boger D.L.","year":"1981","unstructured":"Boger D.L.; Panek J.S.; Diels-Alder reaction of heterocyclic azadienes. I. Thermal cycloaddition of 1, 2, 4-triazine with enamines: simple preparation of substituted pyridines. J Org Chem 1981,46,2179-2182","journal-title":"J Org Chem"},{"key":"ref=66","first-page":"1","volume":"9","author":"Mieczyslawmakosza.","year":"1980","unstructured":"Mieczyslawmakosza. ; Tow-Phase reaction in organic chemistry Survey of progress in chemistry, 1980,9,1-53"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"8343","DOI":"10.1021\/jo901761r","volume":"74","author":"Catozzi N.","year":"2009","unstructured":"Catozzi N.; Edwards M.G.; Raw S.A.; Wasnaire P.; Taylor R.J.K.; Synthesis of the louisianin alkaloid family via a 1,2,4-triazine inverse-electron-demand Diels-Alder approach. J Org Chem 2009,74(21),8343-8354","journal-title":"J Org Chem"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1248\/cpb.35.1378","volume":"35","author":"Konno S.","year":"1987","unstructured":"Konno S.; Ohba S.; Sagi M.; Yamanaka H.; Studies on as-Triazine derivatives IX. Synthesis of 5-Substituted 1,2,4-Triazine derivatives through an addition reaction and substituent oxidation. Chem Pharm Bull (Tokyo) 1987,35,1378-1382","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1002\/cber.19590921014","volume":"92","author":"Metze R.","year":"1959","unstructured":"Metze R.; Scherowsky G.; \u00dcber 1.2.4-Triazine, X.; \u00dcber die Hydrierung von 1.2.4-Triazinen. Chem Ber 1959,92,2481-2486","journal-title":"Chem Ber"},{"key":"ref=70","doi-asserted-by":"publisher","DOI":"10.1002\/352760183X","author":"Eicher T.","year":"2003","unstructured":"Eicher T.; Hauptmann S.;  The Chemistry of Heterocycles: Structure, Reactions, Syntheses, and Applications, The Chemistry of Heterocycles 2003","journal-title":"The Chemistry of Heterocycles: Structure, Reactions, Syntheses, and Applications, The Chemistry of Heterocycles"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1248\/cpb.39.486","volume":"39","author":"Setsuya O.","year":"1991","unstructured":"Setsuya O.; Shoetsu K.; Hiroshi Y.; Studies on as Triazine Derivatives. XVI. Reaction of 1,2,4-Triazinecarbonitriles with carbanions. Chem Pharm Bull (Tokyo) 1991,39,486-488","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1248\/cpb.36.1721","volume":"36","author":"Setsuya O.","year":"1988","unstructured":"Setsuya O.; Mataichi S.; Etsuko T.; Satoshi F.; Kazuhiko H.; Hiroshi Y.; Synthesis of alkenyl-1, 2, 4-triazine derivatives. Chem Pharm Bull (Tokyo) 1988,36,1721-1726","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/anie.196303091","volume":"2","author":"Grundmann C.","year":"1963","unstructured":"Grundmann C.; Syntheses with s-Triazine. Angew Chem Int Ed Engl 1963,2,309-323","journal-title":"Angew Chem Int Ed Engl"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1007\/s10593-009-0294-7","volume":"45","author":"Lozinskii M.O.","year":"2009","unstructured":"Lozinskii M.O.; Chenko A.Y.; Chemistry of heterocyclic compounds at the Institute of Organic Chemistry, National Academy of Sciences of Ukraine. Chem Heterocycl Compd 2009,45,376-399 [Review]","journal-title":"Chem Heterocycl Compd"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"4877","DOI":"10.1016\/0040-4020(72)88095-5","volume":"28","author":"Kreutzberger A.","year":"1972","unstructured":"Kreutzberger A.; Cyanamid als NH-aktive komponate in der synthese von dehydro-N-mannich basen. Tetrahedron 1972,28,4877-4880","journal-title":"Tetrahedron"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1002\/ange.19670792204","volume":"79","author":"Kreutzberger A.","year":"1967","unstructured":"Kreutzberger A.; Gattermannsche Aldehydsynthese mit s-Triazin statt Blausaure. Angew Chem 1967,79,978","journal-title":"Angew Chem"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s10593-009-0243-5","volume":"45","author":"Aksenov A.V.","year":"2009","unstructured":"Aksenov A.V.; Aksenova I.V.; Use of the ring opening reactions of 1, 3, 5-triazines in organic synthesis. Chem Heterocycl Compd 2009,45,130-150 [review]","journal-title":"Chem Heterocycl Compd"},{"key":"ref=78","author":"Bohme R.M.","year":"2008","unstructured":"Bohme R.M.; Dang Q.; 1, 3, 5-Triazine 2008"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/anie.198101021","volume":"20","author":"Jha H.C.","year":"1981","unstructured":"Jha H.C.; Zilliken F.; Breitmaier E.; Isoflavone Synthesis with 1, 3, 5-Triazine. Angew Chem Int Ed Engl 1981,20,102-103","journal-title":"Angew Chem Int Ed Engl"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1039\/j39690001282","volume":"9","author":"Kreutzberger A.","year":"1969","unstructured":"Kreutzberger A.; Stevens M.F.G.; Aminomethinylation of aromatic amines. J Chem Soc C 1969,9,1282-1285","journal-title":"J Chem Soc C"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"4248","DOI":"10.1021\/jo972020y","volume":"63","author":"Kaminski Z.J.","year":"1998","unstructured":"Kaminski Z.J.; Paneth P.; Rudzinski J.; A study on the activation of carboxylic acids by means of 2-Cloro-4,6-Dimethoxy-1,3,5-trizine and 2-Cloro-4,6-diphenoxy-1,3,5-triazine. J Org Chem 1998,63,4248-4255","journal-title":"J Org Chem"}],"container-title":["Mini-Reviews in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/184325","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/184325\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/184325","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T13:52:12Z","timestamp":1638971532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/184325\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,14]]},"references-count":81,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2021,1,14]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389557520666200729160720","relation":{},"ISSN":["1389-5575"],"issn-type":[{"value":"1389-5575","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1,14]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-12-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-25","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}